Psychotropic Panel

Description

The ‘Psychotropic Panel’ test analyzes your DNA to assess your likely reaction to common mental health medications.

Features

• Examines nine genes
• Reports on five categories of medication and one condition
• Must be approved and supervised by a physician

What you’ll receive

You’ll receive a report that provides information about how your DNA affects your response to psychotropic treatments and risk of developing hyperhomocysteinemia. Results will cover the following types of medications:

• Antianxiety
• Select SSRIs/SNRIs
• Tricyclic antidepressants
• Benzodiazepine
• Select psychotropic medications